7^th International Conference and Expo on Molecular & Cancer Biomarkers September 15-16, 2016 Berlin, Germany

ConferenceSeries Ltd invites all the participants from all over the world to attend '7^th International Conference and Expo on Molecular & Cancer Biomarkers' during September 15-16, 2016 in Berlin, Germany which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Molecular Biomarkers 2016 is a platform to discuss and learn about the latest advancements in the field of Molecular and Cancer Biomarkers. Biomarkers have been a great tool in the new generation diagnosis, prognosis and treatment of various diseases. Molecular biomarkers include proteins, lipids, DNA, RNA and several other components in the body. Their applications in some disease pathologies have gained a prominence over period like in cancer and Alzheimer’s diseases. Advanced studies in these fields also opened up a wide scope in development of medical tools and technologies like imaging and companion diagnostics. People form American Oncology society and European Oncology society have been doing research in the field of biomarkers.

ConferenceSeries Ltd, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe

Track 1: Molecular Biomarkers

A biomarker can be anything that can be accurately measured as an indicator of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug intervention. Molecular biomarkers are the biomarkers usually in molecular form. Molecular biomarkers take part in various purposes, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety evaluation. The molecular biomarkers are exclusively being developed and validated to be used in drug development, and used to support approval of drug products.

Molecular biomarkers are mainly classified into Protein biomarkers, Nucleic acid based biomarkers, Lipid biomarkers and Small molecule biomarkers. Almost every pharmaceutical company has been developing molecular biomarker programs. There has been a rapid increase in the number of molecular biomarkers used in drug delivery over the last decade.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  7^th Biomarkers Conference, December 05-07, 2016 Philadelphia, USA; 6^th Genomics Conference, September 12-14, 2016, Berlin, Germany; 6^th Pharmacogenomics Conference, September 12-14, 2016, Berlin, Germany; 8^th Proteomics Conference, March 20-22, 2017, Philadelphia, USA; 12^th World Cancer Conference, September 26-28, 2016, London, UK; American Association for Cancer Research Annual Meeting April 16-20, 2016, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; 2^nd Biomarker Conference September 19-20, 2016, UK; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; 3^rd International Oncology Conference, September 10-11, 2016, UAE.

Track 2: Cancer Biomarkers

A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

Cancer biomarkers can be classified into Nucleic acid based biomarkers, Pathological biomarkers, In silico biomarkers, Imaging biomarkers and Glycoprotein biomarkers based on their structure and functioning. All these topics are discussed in these cancer biomarker conferences.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  12^th World Cancer Conference, September 26-28, 2016, London, UK; Cancer Diagnostics Conference, June 13-15, 2016, Rome, Italy; 2^nd Mass Spectrometry Conference, July 20-22, 2016 Chicago, USA; 3^rd Mass Spectrometry Conference, October 10-11, 2016, Kuala Lumpur, Malaysia; 5^th Medicinal Chemistry Conference, December 05-07, 2016, Phoenix, USA; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; 25th AICR Research Conference, November 14-16, 2016, North Bethesda, USA; National Cancer Institute; 3^rd International Oncology Conference, September 10-11, 2016, UAE; UAE Cancer Congress, October 29-31,2 2015, UAE; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; American Thoracic Society International Conference, May 13-18, 2016, USA; 17^th World Conference on Lung Cancer December, 04-07, 2016 Austria.

Track 3: Clinical biomarkers

Biomarkers which are used for clinical purposes are called clinical biomarkers. Clinical biomarkers along with Pathological biomarkers provide a vibrant and influential methodology to understanding the range of many diseases with uses in judgemental and analytic epidemiology, arbitrary clinical trials, screening for drugs or disease diagnosis and prognosis. Defined as changes in the constituents of cells or body fluids, these clinical biomarkers offer the means for standardized classification of a disease and risk factors, and the can extend the base information about the underlying pathogenesis of disease.

The main researches in clinical biomarkers are done in the fields of drug discovery, oncology, pharmacogenomics and disease diagnostics. This biomarker meeting goes in detail about these fields.

Related Biomarker Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  5^th Computer Aided Drug Designing Conference, December 05-07, 2016, Phoenix, USA; 2^nd Biopharmaceutics Conference, September 14-16, 2016 San Antonio, USA; 2^nd Biologic Drugs Conference, September 14-16, 2016 San Antonio, USA; 2^nd Genetic Engineering Conference, November 14-16, 2016, Atlanta, USA; 2^nd Protein Engineering Conference, November 14-16, 2016, Atlanta, USA; European Organisation for Research and Treatment of Cancer; American Society of Clinical Oncology; Association for International Cancer Research; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand; American Academy of Neurology Annual Meeting April 22-29, 2017, Boston, USA;  4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; 3^rd Annual Drug Discovery USA Congress, 3-4 October 2016, San Diego, USA.

Track 4: Biomarkers and Cancers

Biomarkers play a significant role in cancer prognosis, diagnosis and treatment of cancers these days. There are many types of cancers which are hard to even diagnose. The latest designed biomarkers and their applications provide a great advantage in these cases. Cancer Epidemiology, treatment and latest research is greatly relayed on the biomarkers.

The major types of cancers in which biomarkers are widely being used are breast cancer, lung cancer, prostate cancer and blood cancer. Cancer biomarkers conferences provide a good platform for elaborated discussion on various new researches.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 2^nd Protein Engineering Conference, November 14-16, 2016, Atlanta, USA; 4^th Personalized Medicine Conference, September 22-24, 2016, Phoenix, USA; 4^th Molecular Diagnostics Conference, September 22-24, 2016, Phoenix, USA; 5^th Translational Medicine Conference, November 28-30, 2016, San Francisco, USA; 2^nd Molecular Medicine Conference, September 26-28, 2016, Orlando, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; 3^rd International Oncology Conference, September 10-11, 2016, UAE; UAE Cancer Congress, October 29-31,2 2015, UAE; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; American Thoracic Society International Conference, May 13-18, 2016, USA.

Track 5: Biomarkers and Non-cancerous diseases

Biomarkers plan an important role in various neurological and cardiovascular diseases. The diseases which are incurable from ages are being offered a possible treatment and easy diagnosis with the help of advancements in biomarkers through different diagnostics and imaging technologies. Cardiac biomarkers and neuro biomarkers has brought a great revolution in disease diagnosis and prognosis.

Biomarkers are used in many other non-cancerous diseases. Some of the important ones are Alzheimer’s disease, Neurodegenerative diseases, cardiovascular diseases, and Huntington's disease. 

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 6^th Pharmacogenomics Conference, September 12-14, 2016, Berlin, Germany; 5^th Medicinal Chemistry Conference, December 05-07, 2016, Phoenix, USA; 2^nd Biologic Drugs Conference, September 14-16, 2016 San Antonio, USA; 2^nd Protein Engineering Conference, November 14-16, 2016, Atlanta, USA; 14^th Global Experts Meeting on Nanomaterials, May 04-06, 2017, Dubai, UAE; American Society of Clinical Oncology; National Cancer Institute; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; UAE Cancer Congress, October 29-31,2 2015, UAE; 17^th World Conference on Lung Cancer December, 04-07, 2016 Austria;  4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France.

Track 6: Biomarkers and Radiology

Even though radiological sciences have long history in the medical field, Imaging Biomarkers have given it a new turn. In the modern day radiology, biomarkers have an undividable integral part which has become the major reason for the latest developments in this field. This biomarker conference places a special session to focus on this area of research.

Imaging biomarkers play a significant and crucial role in the modern day medical imaging. Radiology has forwarded to the present state of development only through the help of imaging biomarkers.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  Pediatric Neurology Conference, November 28-30, 2016, Valencia, Spain; 3^rd Clinical Case Reports Meeting, September 02-05, 2017, Dubai, UAE; 2^nd Biopharmaceutics Conference, September 14-16, 2016 San Antonio, USA; 14^th Global Experts Meeting on Nanomaterials, May 04-06, 2017, Dubai, UAE; 4^th Personalized Medicine Conference, September 22-24, 2016, Phoenix, USA; Philippine Cancer Society; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; 2^nd Biomarker Conference September 19-20, 2016, UK; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 3^rd International Oncology Conference, September 10-11, 2016, UAE; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France.

Track 7: Cell Free Biomarkers

Circulating biomarkers allow for the possibility of early, non-invasive detection of cancers. They also represent highly sensitive biomarkers of submissive disease and are capable of reflecting tumour affliction and cancer changing aspects. In the cancer biomarkers conferences, clinical, technical, and biological aspects of cell free biomarkers, and new technologies and techniques will be discussed. Special attention will be given to studies on clinical cases to further see the sights of the applications of these biomarkers and prospective of cell free biomarkers in disease diagnostics.

Circulatory biomarkers, precisely blood biomarkers have a wide area of research with development on various latest techniques, tools and tests for their detection and analysis, specifically aimed on targeted delivery.

Related Biomarker Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 3^rd Euro-Global Experts Meeting on Medical Case Reports, June 30-July 02, 2016 Valencia, Spain; 3^rd Clinical Case Reports Meeting, September 02-05, 2017, Dubai, UAE; 3^rd Experts Meeting on Medical Case Reports, May 09-10, 2016, New Orleans, USA; 2^nd Clinical Trials Conference, August 22-24, 2016, Philadelphia, USA; 15^th World Cardiothoracic Meeting, December 08-09, 2016 Philadelphia, USA; 25th AICR Research Conference, November 14-16, 2016, North Bethesda, USA; American Association for Cancer Research Annual Meeting April 16-20, 2016, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; 3^rd International Oncology Conference, September 10-11, 2016, UAE; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand;  4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia.

Track 8: Predictive Cancer Biomarkers

Cancer biomarkers have become an indispensable part of cancer patient care. With discovery efforts on-going, the next phase towards conversion will involve validation and verification of clinical value. This includes the steps needed to manage the new treatment model from treating clinical symptoms to targeting genomic pathways. Focus will be given to the use of circulating tumour material to follow patients peripherally, both with known metastatic disease and post-surgery. In these Molecular Biomarkers conferences a special importance is given to this field.

Several challenges and solutions for NGS labs, including identifying and prioritizing biomarkers and patient stratification are the topics of high importance to be discussed under this track. Global Biomarkers conferences provide a great platform for to discuss these latest discoveries.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 14^th Clinical Cardiology Conference, November 14-16, 2016, Orlando, USA; 14^th Experimental Cardiology Conference, November 14-16, 2016, Orlando, USA; 9^th Molecular Cardiology Conference, November 28-29, 2016, Sao Paulo, Brazil; 9^th Cellular Cardiology Conference, November 28-29, 2016, Sao Paulo, Brazil; 2^nd Pediatric Cardiology Conference, September 22-24, 2016, Las Vegas, USA; Association for International Cancer Research; Philippine Cancer Society; American Society of Clinical Oncology; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 3^rd International Oncology Conference, September 10-11, 2016, UAE; American Thoracic Society International Conference, May 13-18, 2016, USA; American Academy of Neurology Annual Meeting April 22-29, 2017, Boston, USA; 3^rd Annual Drug Discovery USA Congress, 3-4 October 2016, San Diego , USA.

Track 9: Molecular Biomarkers Discovery

Biomarker discovery requires highly assured identification of a biomarker molecule with real-time quantitative information to indicate which proteins are altering to a statistically pertinent degree in response to disease. The discovery of molecular biomarkers has developed new strategies starting from the initial steps. In the first stage of biomarker discovery proceedings, investigation depends upon mass spectrometry techniques to make unbiased, semiquantitative analysis of changes between healthy and diseased states. The slope of probable molecular biomarkers generated in the discovery stage is to be further substantiated due to the high false positive rate. It is done through supplemental more targeted and quantitative mass spectrometry techniques, such as immuno affinity peptide enrichment.

Under this track, the latest trends in discovery and development of biomarkers and biomarker identification are discussed. There are many new strategies being fashioned in development of molecular biomarkers. In this section advancements of biomarkers in various sectors like clinical biomarkers, paediatric diseases biomarkers, and clinical analysis of NGS samples are covered.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 19^th Interventional Cardiology Conference, August 21-23, 2017, Philadelphia, USA; 13^th European Cardiology Congress, October 17-19, 2016, Rome, Italy; 10^th World Congress on Neurology and Therapeutics, March 27-29, 2017, Madrid, Spain; 7^th Neurologists Annual Meeting on Neurology, August 22-24, 2016 Vienna, Austria; 8^th European Neurology Congress, September 21-23, 2016, Amsterdam, Netherlands; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; American Association for Cancer Research Annual Meeting April 16-20, 2016, USA; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 2^nd Biomarker Conference September 19-20, 2016, UK; 3^rd International Oncology Conference, September 10-11, 2016, UAE; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; 17^th World Conference on Lung Cancer December, 04-07, 2016 Austria.

Track 10: Biomarkers: Validation and Verification

The probable Molecular Biomarkers identified in discovery section need to be validated by using larger sample sets casing a broad section of patient troops. To avoid a potential bottleneck associated with taking a large number of candidates to validation, a verification step is engaged to monitor potential molecular biomarkers to ensure that only the top quality biomarkers from the discovery phase are taken into the expensive validation stage. A high throughput workflow with a minimum of sample preparation is required in the verification stage which provides both high specificity and high sensitivity. Furthermore, the confirmation that a particular methodology is suitable to be used in the biomarker validation phase is given in verification stage. These advanced strategies can be sited at molecular biomarkers conference.

The main areas covered under this track are Omics Technologies in Biomarkers Discovery and Validation, assessment of drug response, advances in analysis, application of various tools in verification and validation of biomarkers and latest diagnostic techniques. All the latest techniques can be publicized in these biomarkers conferences.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 7^th Neurologists Annual Meeting on Neuro Surgery, August 22-24, 2016 Vienna, Austria; Pediatric Neurology Conference, November 28-30, 2016, Valencia, Spain; 2^nd Genetic Engineering Conference, November 14-16, 2016, Atlanta, USA; 8^th Proteomics Conference, March 20-22, 2017, Philadelphia, USA; 2^nd Biopharmaceutics Conference, September 14-16, 2016 San Antonio, USA; European Organisation for Research and Treatment of Cancer; Philippine Cancer Society; National Cancer Institute; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; UAE Cancer Congress, October 29-31,2 2015, UAE; American Thoracic Society International Conference, May 13-18, 2016, USA; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand.

Track 11: Advances of Biomarker testing

Biomarker testing is a group of tests that looks for the molecular signs of health so that doctors can plan the best care. Biomarker testing can also be called as genetic testing or molecular testing. Molecular biomarkers, a foundation of precision oncology, are very important in management of breast cancer, gastro-esophageal cancer and non-small cell lung cancer. Testing practices are intensely deliberated, influencing diagnostic quality and affecting pathologists, oncologists and patients.

The advances in biomarker testing are mainly in the fields of genetic testing, cancers and other diseases in their diagnosis, treatment and imaging. In silico biomarkers, microRNA biomarkers and several other clinical biomarkers evolved in the recent researches have opened up the path for biomarker testing broader.

Related Biomarker Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 6^th Pharmacogenomics Conference, September 12-14, 2016, Berlin, Germany; 2^nd Biologic Drugs Conference, September 14-16, 2016 San Antonio, USA; 2^nd Protein Engineering Conference, November 14-16, 2016, Atlanta, USA; 4^th Molecular Diagnostics Conference, September 22-24, 2016, Phoenix, USA; 14^th Experimental Cardiology Conference, November 14-16, 2016, Orlando, USA; American Society of Clinical Oncology; National Cancer Institute; Association for International Cancer Research; 3^rd Annual Drug Discovery USA Congress, 3-4 October 2016, San Diego , USA; 4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand; American Thoracic Society International Conference, May 13-18, 2016, USA; UAE Cancer Congress, October 29-31,2 2015, UAE.

Track 12: Biomarkers and Personalized Medicine

The ability to look at a patient individually will provide a more precise cancer diagnosis and specific treatment plan. The genetic information from individuals can then be used to effectively treat them, by finding the variations that can account for possible diseases. An individual’s genetic make-up also plays a large part in their extent of response to a certain treatment, and hence, having the knowledge of their genetic content can alter the type of treatment they receive. These approaches are intended to identify individualized patient benefits of therapies, minimize the risk of toxicity and reduce the cost of treatment.

In personalized medicine, biomarkers have a special place, which mends with cancer diagnosis, drug development and usage and cancer genomics. Challenges in these fields are an interesting topic to be discussed as there are radiant solutions emerging.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 3^rd Experts Meeting on Medical Case Reports, May 09-10, 2016, New Orleans, USA; 19^th Interventional Cardiology Conference, August 21-23, 2017, Philadelphia, USA; 7^th Neurologists Annual Meeting on Neurology, August 22-24, 2016 Vienna, Austria; 5^th Computer Aided Drug Designing Conference, December 05-07, 2016, Phoenix, USA; 7^th Biomarkers Conference, December 05-07, 2016 Philadelphia, USA; 25th AICR Research Conference, November 14-16, 2016, North Bethesda, USA; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; American Association for Cancer Research Annual Meeting April 16-20, 2016, USA; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; American Academy of Neurology Annual Meeting April 22-29, 2017, Boston, USA; 17^th World Conference on Lung Cancer December, 04-07, 2016 Austria; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; 3^rd International Oncology Conference, September 10-11, 2016, UAE.

Track 13: Companion Diagnostics

A medical device, which is often an in vitro device and which offers information that is important for the safe and operative use of a respective drug administration or biological product is called a companion diagnostic. These devices help to determine whether a specific therapeutic product’s benefits to a patient will be of more importance that can overshadow any possible serious side effects or risks to treat a patient. These molecular biomarkers conferences invite the latest technologies and techniques to be brought into light.

Partnership between cancer pharmaceutics and diagnostics is a sensitive relation as there are often miscommunications due to lack of knowledge on requirements and feasibilities. The strategies for Rx-Dx partnerships provide a good platform for sharing the knowledge. Development of In-vitro companion diagnostic devices and their commercialization is a rapidly budding area. These diagnostics are useful in the study of surgical oncology.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  2^nd Mass Spectrometry Conference, July 20-22, 2016 Chicago, USA; 3^rd Mass Spectrometry Conference, October 10-11, 2016, Kuala Lumpur, Malaysia; 5^th Medicinal Chemistry Conference, December 05-07, 2016, Phoenix, USA; 14^th Experimental Cardiology Conference, November 14-16, 2016, Orlando, USA; 9^th Molecular Cardiology Conference, November 28-29, 2016, Sao Paulo, Brazil; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; Biomarkers & Precision Medicine USA Congress 2016, October 03-04, 2016, San Diego, USA; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand;  4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA.

Track 14: Biomarkers and Pharmacology

In the biomarker pipeline, the technologies that will enable the use of biomarkers in drug discovery and development vary depending on the research stage. The second stage, biomarker validation and clinical assay development, depends upon extremely sensitive and specific high-throughput immunoassays. The single greatest challenge in discovering biomarkers with clinical utility is the sensitivity and specificity necessary to determine that a biomarker is truly positive for disease or disease toxicodynamics, and can be used to detect deviations from normal. The molecular biomarkers conferences provide good exposure in drug discovery.

Biomarkers have special applications in the areas of translational medicine, clinical development and safety assessment where they are put through several stages of drug discovery, development and validation.

Related Biomarker Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  10^th World Congress on Neurology and Therapeutics, March 27-29, 2017, Madrid, Spain; Cancer Diagnostics Conference, June 13-15, 2016, Rome, Italy; 7^th Neurologists Annual Meeting on Neuro Surgery, August 22-24, 2016 Vienna, Austria; 2^nd Clinical Trials Conference, August 22-24, 2016, Philadelphia, USA; 3^rd Euro-Global Experts Meeting on Medical Case Reports, June 30-July 02, 2016 Valencia, Spain; American Society of Clinical Oncology; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Organisation for Research and Treatment of Cancer; 17^th World Conference on Lung Cancer December, 04-07, 2016 Austria; American Thoracic Society International Conference, May 13-18, 2016, USA; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; UAE Cancer Congress, October 29-31,2 2015, UAE; 3^rd International Oncology Conference, September 10-11, 2016, UAE.

Track 15: Molecular Imaging and Dynamics

Molecular Imaging is a cross-discipline which is an intersection of in vivo imaging and molecular biology. It facilitates the picturing of the cellular function and the supplement of the molecular process in biological processes without disturbing the living organisms. The various fields of study the Molecular Imaging brings life into are diagnosis of diseases such as cancer, cardiovascular diseases and neurological disorders. This technique also donates to the improvisation of the treatment of various diseases and disorders by adjusting the pre-clinical and clinical tests of new drugs. The molecular dynamics meetings are also expected to have a major economic impact due to very prior and more precise diagnosis.

Molecular imaging techniques using biomarkers popularly known as Imaging biomarkers have an important role in screening in various diseases particularly cancer screening using various new generation tools and technologies. There is a special chapter for Clinical imaging and Biomarkers in the Molecular imaging.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences:  Pediatric Neurology Conference, November 28-30, 2016, Valencia, Spain; 3^rd Clinical Case Reports Meeting, September 02-05, 2017, Dubai, UAE; 2^nd Biopharmaceutics Conference, September 14-16, 2016 San Antonio, USA; 14^th Global Experts Meeting on Nanomaterials, May 04-06, 2017, Dubai, UAE; 4^th Personalized Medicine Conference, September 22-24, 2016, Phoenix, USA; Philippine Cancer Society; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; 2^nd Biomarker Conference September 19-20, 2016, UK; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 3^rd International Oncology Conference, September 10-11, 2016, UAE; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France.

Track 16: Oncologists

The study of cancer is called Oncology. An oncologist is a person who specializes in the area of oncology and treating cancer patients. An oncologist manages care and treatment once a person is diagnosed with cancer.

In Germany there are about 2900 oncologists, and more than 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 4^th Molecular Diagnostics Conference, September 22-24, 2016, Phoenix, USA; 5^th Translational Medicine Conference, November 28-30, 2016, San Francisco, USA; 2^nd Molecular Medicine Conference, September 26-28, 2016, Orlando, USA; 14^th Global Experts Meeting on Nanomaterials, May 04-06, 2017, Dubai, UAE; 5^th Computer Aided Drug Designing Conference, December 05-07, 2016, Phoenix, USA; American Society of Clinical Oncology; European Organisation for Research and Treatment of Cancer; American Association for Cancer Research Annual Meeting April 16-20, 2016, USA; American Thoracic Society International Conference, May 13-18, 2016, USA; UAE Cancer Congress, October 29-31,2 2015, UAE; 2^nd Biomarker Conference September 19-20, 2016, UK;  4^th Caribbean Biomedical Research Days Conference, January 16-18, 2017, Rodney Bay, St. Lucia; Asia Pacific Lung Cancer Conference May, 13-16, 2016 Thailand.

Track 17: Case Reports

A case report is an elaborated report of the symptoms, signs, disease diagnosis, treatment, and follow-up of an individual patient usually recorded in medical field. Case reports might comprehend a demographic profile of the patient, but typically mention any unusual or unique occurrences.

In this conference case reports on biomarker diagnostics, drug discovery and imaging are discussed in detail in relevance to molecular and cancer biomarkers. Cancer biomarkers conferences are a big platform to study case reports of these in precision. 

Related Biomarker Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 14^th Experimental Cardiology Conference, November 14-16, 2016, Orlando, USA; 9^th Molecular Cardiology Conference, November 28-29, 2016, Sao Paulo, Brazil; 7^th Neurologists Annual Meeting on Neurology, August 22-24, 2016 Vienna, Austria; 14^th Global Experts Meeting on Nanomaterials, May 04-06, 2017, Dubai, UAE; 7^th Biomarkers Conference, December 05-07, 2016 Philadelphia, USA; National Cancer Institute; Philippine Cancer Society; European Organisation for Research and Treatment of Cancer; 12^th Annual Biomarkers Congress February 2017, Manchester, UK; 12^th Annual Biomarkers & Diagnostics World Congress May 17-19, 2016, USA; 2^nd Biomarker Conference September 19-20, 2016, UK; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; 3^rd International Oncology Conference, September 10-11, 2016, UAE.

Track 18: Entrepreneurs Investment Meet

Self-knowledge is the key ingredient in successful entrepreneurship. Molecular Biomarkers conferences aim to bring together all existing and promising bio entrepreneurs to share capabilities and present new novelties and challenges in biomarker community. Over a million companies are started in the world each year, in which about 5–10 of them are classified into high technology companies. All the Pharmaceutical and Biotech companies are majorly involved in the biomarkers production. Whirling ideas into business ventures is complex and the opportunity appreciation step is critical in new project creation. This idea in the entrepreneur's perception of the association between the invention and final product is converted into a business prototype that describes how the venture generate revenue or provide an suitable yield to the prospective investors. Clinical Research on biomarkers is multifaceted and rapidly expanding and requires an expert knowledge to comprehend the value of the advances and its competitive situation in the industry. Even though scientists are stereotypically the founders of biotech companies, studies indicate that the most effective start-ups are founded by a team which often has two to three individuals with mixed backgrounds like clinical research and Clinical Data Management along with considerable industry experience and a very strong market and product focus at establishment. This two day world-wide molecular and cancer biomarkers conferences will be a highly interactive forum that will bring experts in highly significant areas ranging from Biomarker discovery to latest diagnostics and Rx-Dx relationships. This global biomarker conferences is sure a great platform to discuss the strategized development of industrial production of biomarkers.  

Related Biomarkers Conferences | Cancer Biomarkers Conferences | Molecular Biomarkers Conferences: 8^th Proteomics Conference, March 20-22, 2017, Philadelphia, USA; 12^th World Cancer Conference, September 26-28, 2016, London, UK; Cancer Diagnostics Conference, June 13-15, 2016, Rome, Italy; 2^nd Mass Spectrometry Conference, July 20-22, 2016 Chicago, USA; 3^rd Mass Spectrometry Conference, October 10-11, 2016, Kuala Lumpur, Malaysia; ESMO 2017 Congress, September 08-12, 2017, Madrid, Spain; European Society for Medical Oncology 2016 Congress October, 07-11, 2016 Denmark; ASCO Annual Meeting, June 03-07, 2016, Chicago, USA; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17, 2016, Paris, France; 3^rd International Oncology Conference, September 10-11, 2016, UAE; UAE Cancer Congress, October 29-31,2 2015, UAE; Next Generation Dx Summit, August 23-24, 2016, Washington DC, USA; American Thoracic Society International Conference, May 13-18, 2016, USA.